CT&HM Gr Rds - Improving Population Hlth in Hem Maligs using Nontraditional Risk Markers & Outcomes Assessments - William Wood, MD |
02/28/2017 - 8:00am to 9:00am EST |
CTHM Grand Rounds - Targeting T-cell Costimulation and Cytokine Activation to Prevent GVHD and Preserve GVL - Dr. Brian Betts |
01/31/2017 - 8:00am to 9:00am EST |
CT and HM Grand Rounds - FY17- Improving the outcome of relapsed diffuse large B cell lymphoma - M Jain MD PhD FRCPC ABIM |
12/20/2016 - 8:00am to 9:00am EST |
CT and HM Grand Rounds FY17 - Discovery of the AF1q Gene and its Path...-William Tse, MD, FACP |
12/13/2016 - 8:00am to 9:00am EST |
Cellular Therapy and Hematologic Malignancies Grand Rounds - FY17 - Patient Patient Pearls |
11/22/2016 - 8:00am to 9:00am EST |
CT and HM Grand Rounds FY17- Looking back at UCB transplant, looking forward to chronic GVHD prevention - S. Anand, MD |
11/15/2016 - 8:00am to 9:00am EST |
CT and HM Grand Rounds-SCOT Trial Results - K. Sullivan, MD - FY17 |
11/01/2016 - 8:00am to 9:00am EDT |
CT and HM Grand Rounds: Transplantation for primary cutaneous T-cell lymphoma - Taewoong Choi, MD - FY17 |
10/18/2016 - 8:00am to 9:00am EDT |
CT and HM Grand Rds - FY17 - Allogeneic Hematopoietic Stem Cell Transplant for CLL in the Ibrutinib Era - C. Silva, MD |
09/20/2016 - 8:00am to 9:00am EDT |
Cellular Therapy and Hematologic Malignancies Grand Rounds - FY17 - Journal Club - M. Horwitz, MD |
09/13/2016 - 8:00am to 9:00am EDT |